Detalhe da pesquisa
1.
Risk factors for peripartum depression in women with multiple sclerosis.
Mult Scler
; 28(6): 970-979, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498513
2.
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators.
Mult Scler Relat Disord
; 70: 104484, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608538
3.
Remote Observational Research for Multiple Sclerosis: A Natural Experiment.
Neurol Neuroimmunol Neuroinflamm
; 10(2)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585249
4.
Transitioning From S1P Receptor Modulators to B Cell-Depleting Therapies in Multiple Sclerosis: Clinical, Radiographic, and Laboratory Data.
Neurol Neuroimmunol Neuroinflamm
; 9(4)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35581005
5.
Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and function.
JCI Insight
; 7(4)2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030101
6.
Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis.
Mult Scler Relat Disord
; 56: 103251, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34571415
7.
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity.
medRxiv
; 2021 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580672